Shin Nippon Biomedical Laboratories Ltd
Research Shin Nippon Biomedical Laboratories Ltd (YB3) on Bullrun: market cap EUR 314.32M, P/E 12.8, dividend yield 3.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerYB3
- ExchangeF
- CountryJapan
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 314.32M
- P/E12.8
- Dividend yield3.7%
- Financial periodFY2026
- RevenueJPY 32.52B
- Revenue growth0.3%
- Net incomeJPY 4.57B
- Free cash flowJPY 2.99B
- Gross margin49.9%
Valuation Snapshot
latest market cap is EUR 314.32M; P/E is 12.8; dividend yield is 3.7%.
Peer valuation comparison
Latest P/E is 12.8x versus a Healthcare sector median of 24.46x (47.7% below).
Latest dividend yield is 3.71% versus a Healthcare sector median of 2.11% (75.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 32.52B | JPY 4.57B | JPY 2.99B | 49.9% | 109.69 | JPY 18.54B | JPY 41.26B | JPY 43.12B |
| FY2025 | JPY 32.41B | JPY 4.92B | -JPY 3.90B | 52.3% | 118.29 | JPY 12.03B | JPY 34.47B | JPY 40.02B |
| FY2024 | JPY 26.45B | JPY 5.53B | -JPY 6.50B | 54.0% | 132.86 | JPY 10.27B | JPY 26.19B | JPY 34.11B |
| FY2023 | JPY 25.09B | JPY 6.06B | -JPY 951.70M | 52.0% | 145.56 | JPY 10.53B | JPY 18.76B | JPY 26.21B |
| FY2022 | JPY 17.75B | JPY 7.13B | JPY 4.34B | 54.6% | 171.2 | JPY 6.63B | JPY 9.14B | JPY 19.56B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | EUR 314.32M | 12.8 | 3.6% | 0.27 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.27 EUR, yield 3.7%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.16 JPY |
| FY2025 | 0.27 JPY |
| FY2024 | 0.27 JPY |
| FY2023 | 0.27 JPY |
| FY2022 | 0.33 JPY |
About Shin Nippon Biomedical Laboratories Ltd
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Shin Nippon Biomedical Laboratories Ltd's market cap?
Shin Nippon Biomedical Laboratories Ltd's market capitalization is EUR 314.32M.
What is Shin Nippon Biomedical Laboratories Ltd's P/E ratio?
Shin Nippon Biomedical Laboratories Ltd's price-to-earnings (P/E) ratio is 12.8.
Does Shin Nippon Biomedical Laboratories Ltd pay a dividend?
Shin Nippon Biomedical Laboratories Ltd has a dividend yield of 3.7%.
What does Shin Nippon Biomedical Laboratories Ltd do?
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies.